{"id":1327,"date":"2017-10-23T22:23:58","date_gmt":"2017-10-23T22:23:58","guid":{"rendered":"http:\/\/stg-blogs.bmj.com\/tc\/?p=1327"},"modified":"2017-10-26T10:40:56","modified_gmt":"2017-10-26T10:40:56","slug":"why-tobacco-control-still-wont-publish-tobacco-industry-funded-work-even-if-the-funding-is-laundered-through-pmis-new-independent-foundation","status":"publish","type":"post","link":"https:\/\/stg-blogs.bmj.com\/tc\/2017\/10\/23\/why-tobacco-control-still-wont-publish-tobacco-industry-funded-work-even-if-the-funding-is-laundered-through-pmis-new-independent-foundation\/","title":{"rendered":"Why Tobacco Control still won\u2019t publish tobacco industry funded work, even if the funding is laundered through PMI\u2019s new \u2018independent\u2019 foundation"},"content":{"rendered":"<p>Authors: The Tobacco Control Senior Editorial Team (listed in alphabetical order): Joaquin Barnoya, Joanna Cohen, Coral Gartner, Lisa Henriksen, Sarah Hill, Ruth E. Malone, Richard O\u2019Connor<\/p>\n<p><em>Tobacco Control <\/em>has a normative focus: we strive to publish the best research that informs and advances public health and policy. In this spirit &#8211; and because of a long history of tobacco industry (TI) manipulation, suppression and misrepresentation of scientific data<sup>1<\/sup> &#8211; <em>Tobacco Control<\/em> joined a range of health journals with an explicit policy of not publishing work funded by the TI or from authors who accept TI funding.<sup>2<\/sup> When we established this policy in 2013 we did not anticipate the industry\u2019s creation of foundations to support their (public) research agenda. Recently, however, Philip Morris International (PMI) committed nearly US$1bn to a new \u201cFoundation for a Smoke-Free World,\u201d with the stated goal of funding independent research.<sup>3<\/sup> In light of this development, the editors of <em>Tobacco Control<\/em> reaffirm our 2013 policy, and stress that it will apply to research and researchers funded by such organizations as well as to other types of contributions (such as commentaries or special communications) from TI-supported individuals. This policy is in keeping with the WHO\u2019s Framework Convention on Tobacco Control (FCTC), which recognises \u201ca fundamental and irreconcilable conflict between the tobacco industry\u2019s interests and public health policy interests.\u201d<sup>4<\/sup><\/p>\n<p>While this journal\u2019s stance may seem obvious and necessary to those familiar with the TI\u2019s egregious history of deception, others may question why the normal procedures of peer review and funding disclosure requirements are insufficient guarantors of scientific integrity and independence. Unfortunately, as discussed when the policy was instituted, these measures have been demonstrated to be insufficient to protect against TI manipulation of science to influence policies in service of profit-making.<sup>1,5-8<\/sup> While PMI\u2019s Foundation asserts that its goal is to \u201caccelerate global efforts to reduce health impacts and deaths from smoking\u201d,<sup>9<\/sup> we join with others in the public health community<sup>10-13<\/sup> who note that this goal could be achieved more quickly if multinational tobacco companies such as PMI: (1) committed to a timeline for phasing out commercial cigarette sales &#8211; including in low- and middle-income countries<sup>14<\/sup> &#8211; with imposition of meaningful penalties for insufficient progress toward this goal, and (2) ceased fighting effective tobacco control measures that are informed by evidence published in our pages and elsewhere.<sup>15-17<\/sup> Absent such concrete and enforceable objectives, the suggestion that there could be \u2018shared value\u2019 between the Foundation, whose sole sponsor is PMI, and tobacco control<sup>18<\/sup> is illogical and disingenuous.<\/p>\n<p>The tobacco industry will continue to exploit the harm reduction agenda to reposition itself as a legitimate stakeholder in health research and policy. Regardless of our individual views on the potential harms and benefits of emerging nicotine delivery devices (e.g., electronic cigarettes), the tobacco control community can and should agree on the need to protect public health efforts from the tobacco industry. The industry\u2019s profits continue to be built on the sale of products that have caused a pandemic of suffering, death and disease. There is nothing \u201cnew\u201d or \u201cfresh\u201d about the TI\u2019s interest in promoting some products as less harmful than conventional tobacco,<sup>19<\/sup> nor its efforts to advance its corporate image by funding \u2018independent\u2019 research organisations.<sup>20<\/sup> None of these tactics alters the fundamental conflict of interest between the TI and public health, and none justifies the abandonment of a core principle that has underpinned global tobacco control over the past 15 years.<sup>21<\/sup><\/p>\n<p><strong>References<\/strong><\/p>\n<ol>\n<li>World Health Organization. <em>Tobacco industry interference with tobacco control<\/em>. Geneva: WHO, 2008<\/li>\n<li>Malone R. Changing Tobacco Control\u2019s policy on tobacco industry-funded research. <em>Tobacco Control<\/em> 2013; 22(1): 1-2. doi:10.1136\/tobaccocontrol-2012-05087<\/li>\n<li>Foundation for a Smokefree World. Foundation for a Smokefree World press release, 13 Sept 2017. <a href=\"https:\/\/www.smoke-freeworld.org\/newsroom\/global-foundation-launches-accelerate-end-smoking\">https:\/\/www.smoke-freeworld.org\/newsroom\/global-foundation-launches-accelerate-end-smoking<\/a> (accessed 6 Oct 2017).<\/li>\n<li>World Health Organization. WHO Framework Convention on Tobacco Control Guidelines for Implementation of Article 5.3. Geneva: WHO, 2008 <a href=\"http:\/\/wwwwhoint\/fctc\/guidelines\/article_5_3pdf\">http:\/\/wwwwhoint\/fctc\/guidelines\/article_5_3pdf<\/a> (accessed 6 Oct 2017).<\/li>\n<li>Bero LA, Glantz S, Hong MK. The limits of competing interest disclosures. <em>Tobacco Control<\/em> 2005; 14: 118-126.<\/li>\n<li>Drope J, Chapman S. Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents. <em>J Epidemiol Community Health<\/em> 2001; 55: 588\u2013594<\/li>\n<li>Hammond D, Collishaw NE, Callard C. Secret science: tobacco industry research on smoking behaviour and cigarette toxicity. <em>The Lancet<\/em>; 367(9512):781-7.<\/li>\n<li>Barnoya J, Glantz S. Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the \u201cLatin Project\u201d. <em>Tobacco Control<\/em>. 2002; 11(4): 305-314<\/li>\n<li>Foundation for a Smokefree World \u2013 About Us (website) <a href=\"https:\/\/www.smoke-freeworld.org\/about-us\">https:\/\/www.smoke-freeworld.org\/about-us<\/a> (accessed 16 Oct 2017)<\/li>\n<li>Britton J. A smoke-free generation? Editorial. BMJ 2017 358 :j3944<\/li>\n<li>Daube M, Moodie R, McKee M. Towards a smoke-free world? Philip Morris International\u2019s new Foundation is not credible. <em>The Lancet<\/em> 390(10104): 1722-1733<\/li>\n<li>American Cancer Society. American Cancer Society Statement on Philip Morris International Support of New Effort [press release]. Atlanta: ACS, 2017. <a href=\"http:\/\/pressroom.cancer.org\/releases?item=720\">http:\/\/pressroom.cancer.org\/releases?item=720<\/a> (accessed 8 Oct 2017)<\/li>\n<li>Open letter from 123 groups to PMI. 2017. <a href=\"http:\/\/www.unfairtobacco.org\/en\/open-letter-quitpmi\">www.unfairtobacco.org\/en\/open-letter-quitpmi<\/a> (accessed 16 Oct 2017)<\/li>\n<li>Eriksen M, Mackay J, Schluger N, Islami F, Drope J (2015). The Tobacco Atlas (5th edition). Atlanta: American Cancer Society.<\/li>\n<li>Dubray J, Schwartz R, Chaiton M, O&#8217;Connor S, Cohen JE. The effect of MPOWER on smoking prevalence. <em>Tobacco Control <\/em>2015 24(6):540-542<\/li>\n<li>World Health Organization. WHO report on the global tobacco epidemic, 2008: the MPOWER package. Geneva: World Health Organization, 2008<\/li>\n<li>Levy DT, Chaloupka F, Gitchell J. The effects of tobacco control policies on smoking rates: a tobacco control scorecard. <em>J Public Health Manag Pract <\/em>2004;10:338\u201353<\/li>\n<li>Yach D. Foundation for a Smoke-free World. <em>The Lancet<\/em> 390(10104): 1807-1810 <a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(17)32602-8\/fulltext\">http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(17)32602-8\/fulltext<\/a><\/li>\n<li>Bero L (1997) More documentation of the futile search for a \u201csafer\u201d cigarette (book review). <em>Tobacco Control<\/em> 6(3):250\u2013251<\/li>\n<li>Brandt AM. Inventing conflicts of interest: a history of tobacco industry tactics. <em>Am J Public Health<\/em> 2012; 102: 63\u201371<\/li>\n<li>Collin J. Tobacco control, global health policy and development: towards policy coherence in global governance. Tobacco Control 2012; 21(2): 274-280<\/li>\n<\/ol>\n<p><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Authors: The Tobacco Control Senior Editorial Team (listed in alphabetical order): Joaquin Barnoya, Joanna Cohen, Coral Gartner, Lisa Henriksen, Sarah Hill, Ruth E. Malone, Richard O\u2019Connor Tobacco Control has a normative focus: we strive to publish the best research that informs and advances public health and policy. In this spirit &#8211; and because of a [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/stg-blogs.bmj.com\/tc\/2017\/10\/23\/why-tobacco-control-still-wont-publish-tobacco-industry-funded-work-even-if-the-funding-is-laundered-through-pmis-new-independent-foundation\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6830,1715,2143],"tags":[],"class_list":["post-1327","post","type-post","status-publish","format-standard","hentry","category-fake-news","category-marketingadvertising","category-tobacco-industry"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts\/1327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/comments?post=1327"}],"version-history":[{"count":0,"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts\/1327\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/media?parent=1327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/categories?post=1327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/tc\/wp-json\/wp\/v2\/tags?post=1327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}